ELPC ELPC
Company Profile ↓Company Overview
ELPC (ELPC) is a publicly traded company listed on with a market capitalization of $34.57B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 34.2% per year over the last five years.
Trades at an undemanding P/E of 3.2.
Operating margin of 17.4% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $26.12B (+15.3% YoY); net profit $2.69B.
- Trailing 12 Months Year-on-year growth — revenue +15.3%, earnings -4.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 8.3%, profit CAGR 34.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 8.34% |
| 1 Year: | 15.30% |
Compounded Profit Growth
| 5 Years: | 34.22% |
| 1 Year: | -4.31% |
Stock Price Performance
| 1 Year: | +47.97% |
| 6 Months: | +12.46% |
| 3 Months: | -9.95% |
| 1 Month: | +0.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)48.36 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 34.2% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 5.89B | 6.23B | 6.81B | 7.19B | 7.07B |
| Cost of Revenue | - | 3.59B | 4.14B | 4.74B | 7.99B | 4.54B |
| Gross Profit | - | 2.30B | 2.09B | 2.07B | -797.00M | 2.53B |
| Operating Expenses | - | 1.02B | 967.01M | 1.16B | -2.07B | 1.09B |
| Operating Income | - | 1.28B | 1.12B | 913.10M | 1.28B | 1.44B |
| EBITDA | - | 2.03B | 1.20B | 937.89M | 1.52B | 2.24B |
| Interest Expense | - | 744.16M | 19.00M | 21.75M | 177.47M | 822.51M |
| Pretax Income | - | 935.01M | 819.69M | 539.61M | 952.35M | 1.02B |
| Tax Provision | - | 270.34M | 246.12M | 175.44M | -114.28M | 321.19M |
| Net Income | - | 665.51M | 572.14M | 384.22M | 1.07B | 692.04M |
| Diluted EPS | - | 0.90 | 0.77 | 0.52 | 1.44 | 0.93 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 20.54B | 21.48B | 22.65B | 26.12B |
| Cost of Revenue | - | 15.61B | 16.58B | 17.76B | 20.46B |
| Gross Profit | - | 4.93B | 4.90B | 4.89B | 5.66B |
| Operating Expenses | - | 3.65B | 1.71B | 1.29B | 1.11B |
| Operating Income | - | 1.28B | 3.19B | 3.60B | 4.55B |
| EBITDA | - | 2.41B | 4.10B | 4.62B | 4.97B |
| Interest Expense | - | 234.03M | 230.08M | 243.70M | 240.95M |
| Pretax Income | - | 942.89M | 2.49B | 2.91B | 3.25B |
| Tax Provision | - | -281.10M | 354.06M | 599.43M | 577.62M |
| Net Income | - | 1.11B | 2.26B | 2.81B | 2.69B |
| Diluted EPS | - | 1.63 | 3.03 | 3.77 | 3.62 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 49.70B | 55.82B | 57.38B | 60.41B |
| Current Assets | - | 9.33B | 13.72B | 13.04B | 10.88B |
| Cash & Equivalents | - | 2.68B | 5.63B | 4.16B | 3.13B |
| Inventory | - | 194.85M | 174.73M | 136.32M | 173.40M |
| Receivables | - | 3.34B | 3.76B | 3.96B | 4.30B |
| Total Liabilities | - | 28.57B | 31.63B | 31.75B | 37.32B |
| Current Liabilities | - | 7.16B | 9.31B | 10.34B | 11.06B |
| Long Term Debt | - | 10.83B | 13.06B | 13.99B | 17.95B |
| Total Debt | - | 12.73B | 15.23B | 17.57B | 20.31B |
| Total Equity | - | 20.82B | 23.89B | 25.67B | 23.13B |
| Shares Outstanding | - | 2.74B | 2.98B | 2.98B | 2.98B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 3.90B | 3.52B | 3.39B | 3.03B |
| Investing Cash Flow | - | -2.77B | -3.14B | -5.74B | -1.76B |
| Financing Cash Flow | - | -1.92B | 2.70B | 803.86M | -2.30B |
| Capital Expenditure | - | -390.26M | -218.19M | -4.24B | -205.89M |
| Free Cash Flow | - | 3.51B | 3.30B | -842.38M | 2.82B |
| Net Change in Cash | - | -920.44M | 3.08B | -1.54B | -1.03B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 24.0% | 22.8% | 21.6% | 21.7% |
| Operating Margin % | - | 6.2% | 14.8% | 15.9% | 17.4% |
| Net Margin % | - | 5.4% | 10.5% | 12.4% | 10.3% |
| ROE % | - | 5.3% | 9.5% | 10.9% | 11.6% |
| ROCE % | - | 3.0% | 6.8% | 7.7% | 9.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ELPC
Zacks.com featured highlights include Invesco Aveanna Healthcare, Companhia Paranaense de Energia - COPEL and ArcBest
Invesco is among four discounted PEG value picks as easing rate expectations and valuation gaps renew interest in fundamentally strong stocks.
4 Discounted PEG Value Picks Following the June CPI Inflation Report
June CPI eased, boosting hopes for Fed rate cuts as discounted PEG value stocks like Invesco, Aveanna, COPEL and ArcBest draw attention.
Are Utilities Stocks Lagging California Water Service Group (CWT) This Year?
Here is how California Water Service Group (CWT) and Companhia Paranaense de Energia - Copel Unsponsored ADR (ELPC) have performed compared to their sector so far this year.
Here Is Why Gerdau (GGB) Is One Of The Top NYSE Penny Stocks According To Hedge Funds
Gerdau S.A. (NYSE:GGB) is one of the 15 best NYSE penny stocks to buy according to hedge funds. As of the close of play on July 7, Gerdau S.A. (NYSE:GGB) carried a moderately bullish consensus sentiment. Based on a median 1-year price targe…
Is Companhia Paranaense de Energia - Copel Unsponsored ADR (ELPC) Stock Outpacing Its Utilities Peers This Year?
Here is how Companhia Paranaense de Energia - Copel Unsponsored ADR (ELPC) and Enel SpA (ENLAY) have performed compared to their sector so far this year.
Gerdau S.A. (GGB) Strengthens Edge in Brazil Energy Market with Dona Francisca Energética Hydro Plant Acquisition
Gerdau S.A. (NYSE:GGB) is one of the mining stocks with the highest dividends. On June 16, Gerdau S.A. (NYSE:GGB) reached an agreement to acquire Companhia Paranaense de Energia’s entire 23.03% equity stake in the Dona Francisca Energética …
ELPC — Frequently Asked Questions
What is the current share price of ELPC?
As of 2026-08-05 17:25 PDT, ELPC trades at $11.59 on NASDAQ/NYSE. Its 52-week range is $7.82 to $13.39.
What is the market capitalisation of ELPC?
ELPC has a market capitalisation of $34.57B on NASDAQ/NYSE.
What is the P/E ratio of ELPC?
ELPC trades at a trailing price-to-earnings (P/E) ratio of 3.20. Its price-to-book (P/B) ratio is 1.49.
What is the return on equity (ROE) of ELPC?
ELPC has a return on equity (ROE) of 11.62%. Its return on capital employed (ROCE) is 9.23%.
Is ELPC a good stock to buy?
This page provides a data-driven analysis of ELPC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.